Addex Therapeutics to Release Half-Year 2023 Financial Results and Host Conference Call on August 10, 2023

Geneva, Switzerland, August 3, 2023 – Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it will...

Related Keywords

Switzerland ,United States ,Geneva ,Genè ,Swiss ,American ,Mikhail Kalinichev ,Mike Sinclair ,Tim Dyer ,Janssen Pharmaceuticals Inc ,Nasdaq ,Swiss Exchange ,Addex Therapeutics ,Translational Science ,Announce Half Year ,Provides Corporate Update ,Conference Call ,Participant Dial In ,Janssen Pharmaceuticals ,American Depositary Shares ,Forward Looking Statements ,Private Securities Litigation Reform Act ,Addex Therapeutic Annual Report ,Addex Therapeutic ,Markets ,